Xuanwu Hospital, Capital Medical University
Beijing, China
NCT Number: NCT07788209
This retrospective study aimed to validate and compare two individualized, closed-loop, AI-driven computerized cognitive training programs with a conventional non-AI training program in a real-world clinical setting. Using objective tablet-recorded data from patients' prior treatment, participants were categorized into three groups according to the training recommendation strategy they actually received. Changes in global cognitive function and specific cognitive domains after 8 weeks of training were compared across groups to evaluate the association between different training strategies and cognitive outcomes.
This study is active but is not currently recruiting participants.
Notify Me45 year and older
All sexes
Observational
Beijing, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants received a multi-domain computerized cognitive training program delivered on a tablet. The program used an AI-based adaptive, closed-loop recommendation strategy to individualize training tasks and difficulty levels, with the goal of maximizing cognitive improvement over the training period.
Participants received a multi-domain computerized cognitive training program delivered on a tablet. The program used an AI-based adaptive, closed-loop recommendation strategy to individualize training tasks and difficulty levels, with the goal of maximizing cognitive task performance during training.
Participants received a conventional computerized cognitive training program delivered on a tablet. Training tasks were randomly selected within the cognitive domains corresponding to participants' symptomatic impairments and difficulty levels were fixed.
Time frame: From baseline (week 1) to week 8
The general cognitive ability was assessed by the Cognitive Index, calculated from task performance scores. The CCT platforms recorded the Cognitive Index in real time on a daily basis. Weekly Cognitive Index values were computed as the mean of the daily scores recorded over each 7-day period. The change in Cognitive Index from baseline to week 8 is reported.
Time frame: From baseline (week 1) to week 8
Seven cognitive subdomains include perception, attention, memory, language, executive function, thinking, and emotion. Domain-specific cognitive ability was calculated by averaging the scores of all tasks targeting the same cognitive domain. The change from baseline to week 8 is reported.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the Cognitive Index. Training dose was defined as the cumulative number of completed training tasks up to each training day. The outcome measure was the model-estimated asymptote parameter, representing the maximum attainable improvement in the Cognitive Index with increasing training dose. Higher values indicate greater maximum attainable improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the Cognitive Index. Training dose was defined as the cumulative number of completed training tasks up to each training day. The outcome measure was the model-estimated learning-rate parameter, representing the rate at which the Cognitive Index improved with increasing training dose. Higher values indicate a faster rate of improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the perception subdomain index. The outcome measure was the model-estimated asymptote parameter, representing the maximum attainable improvement in perception with increasing training dose. Higher values indicate greater maximum attainable improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the perception subdomain index. The outcome measure was the model-estimated learning-rate parameter, representing the rate at which performance in the perception subdomain improved with increasing training dose. Higher values indicate a faster rate of improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the attention subdomain index. The outcome measure was the model-estimated asymptote parameter, representing the maximum attainable improvement in attention with increasing training dose. Higher values indicate greater maximum attainable improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the attention subdomain index. The outcome measure was the model-estimated learning-rate parameter, representing the rate at which performance in the attention subdomain improved with increasing training dose. Higher values indicate a faster rate of improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the memory subdomain index. The outcome measure was the model-estimated asymptote parameter, representing the maximum attainable improvement in memory with increasing training dose. Higher values indicate greater maximum attainable improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the memory subdomain index. The outcome measure was the model-estimated learning-rate parameter, representing the rate at which performance in the memory subdomain improved with increasing training dose. Higher values indicate a faster rate of improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the language subdomain index. The outcome measure was the model-estimated asymptote parameter, representing the maximum attainable improvement in language with increasing training dose. Higher values indicate greater maximum attainable improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the language subdomain index. The outcome measure was the model-estimated learning-rate parameter, representing the rate at which performance in the language subdomain improved with increasing training dose. Higher values indicate a faster rate of improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the executive function subdomain index. The outcome measure was the model-estimated asymptote parameter, representing the maximum attainable improvement in executive function with increasing training dose. Higher values indicate greater maximum attainable improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the executive function subdomain index. The outcome measure was the model-estimated learning-rate parameter, representing the rate at which performance in the executive function subdomain improved with increasing training dose. Higher values indicate a faster rate of improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the thinking subdomain index. The outcome measure was the model-estimated asymptote parameter, representing the maximum attainable improvement in thinking with increasing training dose. Higher values indicate greater maximum attainable improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the thinking subdomain index. The outcome measure was the model-estimated learning-rate parameter, representing the rate at which performance in the thinking subdomain improved with increasing training dose. Higher values indicate a faster rate of improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the emotion subdomain index. The outcome measure was the model-estimated asymptote parameter, representing the maximum attainable improvement in emotion with increasing training dose. Higher values indicate greater maximum attainable improvement.
Time frame: From baseline (week 1) to week 8
A dose-response function was fitted to model the relationship between cumulative training dose and change from baseline in the emotion subdomain index. The outcome measure was the model-estimated learning-rate parameter, representing the rate at which performance in the emotion subdomain improved with increasing training dose. Higher values indicate a faster rate of improvement.
Xuanwu Hospital, Beijing
Other
Scaffolding in AI-Empowered Cognitive Training Improves Outcomes in Cognitive Impairment: A Real-world Retrospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06154174
Body Weight, Body Weight Changes
Makhwira, Chikwawa, Malawi
View Trial DetailsNCT06182995
Brain Diseases, Central Nervous System Diseases
Winston-Salem, North Carolina, United States
View Trial DetailsNCT05431192
Cardiovascular Diseases, Cognition Disorders
Providence, Rhode Island, United States
View Trial DetailsNCT05109169
Brain Diseases, Central Nervous System Diseases
Helsinki, Finland
View Trial Details